Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 470 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 101-125 of 390 matching filings.

Per page
25
Current page
5
SC TO-I/A File 005-91495

SC TO-I/A

Filing date
15 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-272569

REGISTRATION STATEMENT

Filing date
09 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40699

DEF 14A

Filing date
05 Jun 2023
Reporting date
05 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40699

PRELIMINARY PROXY STATEMENT

Filing date
25 May 2023
Reporting date
07 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91495

SC 13G filing

Filing date
19 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91495

AMENDMENT NO. 4 TO THE SCHEDULE 13D

Filing date
12 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I File 005-91495

SCHEDULE TO-I

Filing date
11 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91495

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91495

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91495

SABBY 13GA PMCB 1.10.23

Filing date
10 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Dec 2022
Reporting date
28 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2022
Reporting date
28 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2022
Reporting date
28 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40699

DEFINITIVE PROXY STATEMENT

Filing date
25 Nov 2022
Reporting date
28 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40699

SCHEDULE 14A

Filing date
15 Nov 2022
Reporting date
28 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .